Q2 2026 Encompass Health Corp Earnings Call Transcript

Aug 6, 2026 / 02:00 PM GMT

Release Date Price: $124.82 (+12.55%)

Transcript 10-Q8-K

Key Points

Positve

Encompass Health Corp (EHC) delivered strong Q2 2026 results with revenue growth of 9.6%, adjusted EBITDA growth of 9.2%, and adjusted EPS growth of 10.7%, leading to another guidance raise.
Patient outcomes remain excellent, with a discharge-to-community rate of 84.7% and discharge-to-acute rate of 8.4%, both exceeding industry averages.
The company's investment in career ladder programs is yielding significant benefits, including a nurse turnover rate of 19% (a 12+ year low) and therapy turnover of just over 7% (a 5-year low), which is reducing reliance on premium labor.
The repeal of North Carolina's certificate of need (CON) law presents a major growth opportunity, with an initial prioritization of 15 markets and 3 already under contract, positioning the company for expansion in a large underserved market.
The 'admit and appeal' strategy against Medicare Advantage denials is proving highly successful, with an 89% success rate on fully adjudicated cases, validating the medical necessity of the care provided and creating a potential template for broader rollout.

Negative

The company absorbed an $11.5 million year-over-year decrease in net provider tax impact, primarily due to out-of-period adjustments for the fiscal year 2025 Florida Medicaid program, which negatively affected EBITDA.
Wage inflation is expected to be higher than previously anticipated, with full-year 2026 SWB per FTE growth now projected at 3.5% to 4%, driven by increased participation in the career ladder programs.
Medicare Advantage plans continue to present a significant challenge, with a substantial disparity in denial rates compared to Medicare fee-for-service, requiring costly administrative efforts to combat.
New hospital opening and ramp-up costs are elevated, with $6.9 million incurred in Q2 and expectations of $18 to $22 million for the full year, which pressures near-term profitability.
The company faces ongoing uncertainty regarding the sustainability of higher patient acuity levels, which have driven favorable pricing but could fluctuate in future quarters, making it difficult to project consistent growth.

Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N

EHC.N - Encompass Health Corp
Q2 2026 Encompass Health Corp Earnings Call
Aug 06, 2026 / 02:00PM GMT

=====================
Presentation
--------------------------------------------------------------------------------
Unidentified_1 [1]
--------------------------------------------------------------------------------
Thank you for your meeting will begin shortly if you need assistance, please press 0 and a team will be happy to help you.

Mm.

Assistance at any time, please press 0 and will be happy to help you.

Mm

Mm.

Mm.

Please stand by, your meeting is about to begin.

Yeah.

Everyone and welcome to Encompass Health second quarter 2026 earnings conference call at this time, participants at their lines will be in listen-only mode.

After the speakers there will be a question-and-answer period.

If you would like to ask a question during this time, please press star 1 on your telephone keypad, you'll be limited to 1 question question, today's conference

Already have an account? Log in

Get the full story

Subscribe Now

	Access to All Earning Calls and Stock Analysis
	30-Year Financial on one screen
	All-in-one Stock Screener with unlimited filters
	Customizable Stock Dashboard
	Real Time Insider Trading Transactions
	8,000+ Institutional investors’ 13F holdings
	Powerful Excel Add-in and Google sheets Add-on
	All data downloadable
	Quick customer support
	And much more...

7-Day Free Trial · Cancel Anytime

Subscription fee may be tax deductible.

Excellent

4.6 out of 5

Trustpilot

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Calculators Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App Newsletters Signup 中文

Education

Financial Glossary Tutorials FAQ Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by FactSet. Analyst estimates data is sourced from both Refinitiv and FactSet, with priority given to Refinitiv data. Data is updated daily.